ReviewWorld journal of gastroenterology2012
Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.
Review in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.PloS one · 2014Trial
- Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance.PloS one · 2014Trial
- Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease.The Korean journal of internal medicine · 2013Trial
- Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease.Annals of medicine · 2023Article
- Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.Internal medicine (Tokyo, Japan) · 2023Observational
- Magnetic resonance elastography of the liver: everything you need to know to get started.Abdominal radiology (New York) · 2022Review
- Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study.Scientific reports · 2021Article
- The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population.Lipids in health and disease · 2021Article
- Chinese tree shrews as a primate experimental animal eligible for the study of alcoholic liver disease: characterization and confirmation by MRI.Experimental animals · 2020Article
- Review
- Noninvasive Evaluation of Liver Function in Morbidly Obese Patients.Gastroenterology research and practice · 2019Article
- Serum Caspase-Cleaved Cytokeratin (M30) Indicates Severity of Liver Dysfunction and Predicts Liver Outcome.Annals of transplantation · 2018Article
- Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae.Biomolecules · 2018Article
- Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis.Therapeutic advances in gastroenterology · 2018Review
- The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.PloS one · 2017Article
- Non-alcoholic fatty liver disease in 2016.British medical bulletin · 2016Review
- Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.Medicine · 2016Observational
- High prevalence of chronic hepatitis D virus infection in Eastern Turkey: urbanization of the disease.Archives of medical science : AMS · 2016Article
- Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats.Preventive nutrition and food science · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High prevalence of non-alcoholic fatty liver disease (NAFLD) and very diverse outcomes that are related to disease form and severity at presentation have made the search for noninvasive diagnostic tools in NAFLD one of the areas with most intense development in hepatology today. Various methods have been investigated in the recent years, including imaging methods like ultrasound and magnetic resonance imaging, different forms of liver stiffness measurement, various biomarkers of necroinflammatory processes (acute phase reactants, cytokines, markers of apoptosis), hyaluronic acid and other biomarkers of liver fibrosis. Multicomponent tests, scoring systems and diagnostic panels were also developed with the purposes of differentiating non-alcoholic steatohepatitis from simple steatosis or discriminating between various fibrosis stages. In all of the cases, performance of noninvasive methods was compared with liver biopsy, which is still considered to be a gold standard in diagnosis, but is by itself far from a perfect comparative measure. We present here the overview of the published data on various noninvasive diagnostic tools, some of which appear to be very promising, and we address as well some of still unresolved issues in this interesting field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.